Letter
par
Ontario Drug Policy Research Network
Date de publication
2024
Géographie
Canada
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Non
Évalué par des pairs
No
L’objectif
The aim of this submission is to clarify the research and statistics behind injection-related infections among individuals on safer opioid supply (SOS)--daily dispensed immediate-release hydromorphone.
Constatations/points à retenir
Infections are several times more likely among those injecting controlled release hydromorphone whereas SOS prescribers routinely prescribe immediately release hydromorphone tablets. Likewise, those on SOS have a much higher rate of previous hospitalization due to injection-related infection, which is reduced upon initiation of SOS treatment.
Mots clés
About PWUD
Advocacy
Evidence base
Hospitals
Injecting drugs
Opioids
Safer supply
